hers and semaglutide Novo Nordisk Drops Hims & Hers: Inside the Compounded GLP-1 Crisis Questions about Hers & compound

Long-term data (4 years) shows people maintain about 10% weight loss if they stay on the medication

Long-term success with semaglutide relies on precision and consistency, especially when your body starts to adapt

What this means for real people For readers wondering whether the science or the price should sway decisions, here is a practical take by experts - If your goal is diabetes control and modest weight loss, semaglutide formulations (Ozempic) remain a mainstream choice, supported by cardiovascular outcomes data and diabetes approvals

If youre not losing weight on semaglutide, it could be that you havent been using it long enough, the dosage may be too low, or that diet and activity adjustments need to be made

While we await findings from bigger studies, its difficult to interpret the conflicting results